Floatz logo

Cladribine

Allogeneic Hematopoeitic Stem Cell Transplantation

Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineSmall moleculePhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

75 Active assets in the Allogeneic Hematopoeitic Stem Cell Transplantation cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
The First Affiliated Hospital of Soochow University
Phase 3BBB
Busulphan
Institute of Hematology & Blood Diseases Hospital, China
Phase 3BBB
FILGRASTIM
National Cancer Institute (NCI)
Phase 2/3BBB
Decitabine
Chinese PLA General Hospital
Phase 4BBB
Cyclophosphamide
St. Jude Children's Research Hospital
Phase 3BBB

View all 50 →

Same molecule, other indications

Cladribine is also rated in:

relapsing-remitting multiple sclerosisDormant
BBB
Indicative ·
76 / 100
View asset →
lymphoblastic lymphomaDormant
BBB
Indicative ·
75 / 100
View asset →
multiple sclerosisDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →